פרגניקול 6000 IU וטרינרי Izrael - héber - Ministry of Health

פרגניקול 6000 iu וטרינרי

comex ltd - pregnant mare serum gonadotrophin 6000 iu - powder for solution for injection - induce ovulation in anovulatory animals, notable anoestrus sheep, cattle, bitch and pigs.

פרגניקול 20000 IU וטרינרי Izrael - héber - Ministry of Health

פרגניקול 20000 iu וטרינרי

comex ltd - pregnant mare serum gonadotrophin 20000 iu - powder for solution for injection - induce ovulation in anovulatory animals, notable anoestrus sheep, cattle, bitch and pigs.

כרונוג'סט PMSG וטרינרי 600 IU Izrael - héber - Ministry of Health

כרונוג'סט pmsg וטרינרי 600 iu

intervet ( israel) ltd - pregnant mare serum gonadotrophin 600 iu/vial - powder for solution for injection - induction and synchronization of oestrus and ovulation in ewes, and goats.

כרונוג'סט PMSG וטרינרי 6000 I.U Izrael - héber - Ministry of Health

כרונוג'סט pmsg וטרינרי 6000 i.u

intervet ( israel) ltd - pregnant mare serum gonadotrophin 6000 iu/vial - powder for solution for injection - induction and synchronization of oestrus and ovulation in ewes and goats.

לובריס 75 Izrael - héber - Ministry of Health

לובריס 75

merck serono ltd - luteinizing hormone - אבקה להכנת תמיסה לזריקה - luteinizing hormone 75 iu/ml - gonadotropins - luveris in association with a follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.

רקובל 12 Izrael - héber - Ministry of Health

רקובל 12

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 12 mcg / 0.36 ml - follitropin delta

רקובל 36 Izrael - héber - Ministry of Health

רקובל 36

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 36 mcg / 1.08 ml - follitropin delta

רקובל 72 Izrael - héber - Ministry of Health

רקובל 72

ferring pharmaceuticals ltd - follitropin delta - תמיסה להזרקה - follitropin delta 72 mcg / 2.16 ml - follitropin delta

פיורגון תמיסה להזרקה Izrael - héber - Ministry of Health

פיורגון תמיסה להזרקה

organon pharma israel ltd., israel - follitropin beta - תמיסה להזרקה - follitropin beta 833 iu / 1 ml - follitropin beta - follitropin beta - puregon is indicated for the treatment of female infertility in the following clinical situations: anovulation (including polycystic ovarian disease, pcod) in women who have beenunresponsive to treatment with clomiphene citrate. controlled ovarian hyperstimulation to induce the development of multiple follicles in medically assisted reproduction programs [ e.g. in vitro fertilisation/embryo transfer (ivf/et), gamete intra-fallopian transfer (gift) and intracytoplasmic sperm injection (icsi)]. in the male : deficient spermatogenesis due to hypogonadotrophic hypogonadism.

דיפרילין  3.75 מג Izrael - héber - Ministry of Health

דיפרילין 3.75 מג

medison pharma ltd - triptorelin as acetate - אבקה וממס להכנת תרחיף להזרקה - triptorelin as acetate 3.75 mg/vial - triptorelin - triptorelin - prostate cancer: treatment of prostate cancer with metastases. patients who have not previously received hormone therapy show a more marked response to the treatment and respond more frequently if the patient has not previously receieved another hormone treatment. precocious puberty: (before 8 years in girls and 10 years in boys). genital and extragenital endometriosis (stage i to stage iv): treatment should not be administered for more than 6 months. it is not recomended to start a second treatment course with triptorelin or another gnrh analogue. treatment of uterine fibromyomas prior to surgery: associated with anaemia ( haemoglobin less than, or equal to 8 g/dl). when a reduction in the size of the fibromyoma is necessary to facilitate or modify the surgical technique: endoscopic surgery, transvaginal surgery. the treatment duration is restricted to 3 months. female infertility: supplementary treatment in combination with gonadotrophins (hmg, fsh, hcg) to induce ovulation with a view to in vitro fertilisa